dalteparin has been researched along with Ischemic Stroke in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keskin, H | 1 |
| Keskin, F | 1 |
| Yildirim, E | 1 |
| Saritas, S | 1 |
| Polat, G | 1 |
| Colak, A | 1 |
| Laloglu, F | 1 |
| Guler, MA | 1 |
| Ozay, M | 1 |
| Alp, H | 1 |
| Yasutaka, Y | 1 |
| Fujioka, S | 1 |
| Tsuboi, Y | 1 |
| Oyabu, K | 1 |
| Shibaguchi, H | 1 |
| Kamimura, H | 1 |
2 other studies available for dalteparin and Ischemic Stroke
| Article | Year |
|---|---|
Case of Venous Thromboembolia Under Enoxaparin Prophylaxis After Recovering From Acute Ischemic Stroke in Consequence of COVID-19-Related MIS-C.
Topics: Anticoagulants; Brain Ischemia; COVID-19; Enoxaparin; Humans; Ischemic Stroke; Systemic Inflammatory | 2022 |
Liver toxicity of intravenous heparin treatment in patients with acute ischemic stroke.
Topics: Anticoagulants; Cerebral Infarction; Edaravone; Enoxaparin; Heparin; Humans; Ischemic Stroke; Liver; | 2023 |